Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
© NHSBT

Radcliffe Department of Medicine's Professor David Roberts, who is also Associate Medical Director, NHS Blood and Transplant, is co-leading an NHS Blood and Transplant programme to collect convalescent plasma from people who have recovered from COVID-19 to support a national clinical trial. The UK Department of Health and Social Care announced the programme on Saturday 25 April.

Professor Hugh Watkins, who heads the Radcliffe Department of Medicine said “We are keen to bring the expertise and facilities we have here at the department to help solve what is likely to be the greatest public health crisis of our generation.”

“Transfusion of antibody-containing plasma from recovered patients has been an effective treatment strategy for other viral diseases, so this is an important trial.”

The transfusions will be done through the existing REMAP-CAP trial and further trial options are being explored.

Read more on the Radcliffe Department of Medicine website

Read more about the trial on the NHS Blood and Transplant website